NUVESSA Drug Patent Profile
✉ Email this page to a colleague
When do Nuvessa patents expire, and what generic alternatives are available?
Nuvessa is a drug marketed by Chemo Research Sl and is included in one NDA. There are seven patents protecting this drug and one Paragraph IV challenge.
This drug has sixteen patent family members in nine countries.
The generic ingredient in NUVESSA is metronidazole. There are eighteen drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nuvessa
A generic version of NUVESSA was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NUVESSA?
- What are the global sales for NUVESSA?
- What is Average Wholesale Price for NUVESSA?
Summary for NUVESSA
International Patents: | 16 |
US Patents: | 7 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 172 |
Patent Applications: | 4,003 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in NUVESSA? | NUVESSA excipients list |
DailyMed Link: | NUVESSA at DailyMed |
![NUVESSA drug patent expirations Drug patent expirations by year for NUVESSA](/p/graph/s/t/NUVESSA-patent-expirations.png)
Pharmacology for NUVESSA
Drug Class | Nitroimidazole Antimicrobial |
Paragraph IV (Patent) Challenges for NUVESSA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
NUVESSA | Vaginal Gel | metronidazole | 1.30% | 205223 | 1 | 2022-03-30 |
US Patents and Regulatory Information for NUVESSA
NUVESSA is protected by seven US patents.
Patents protecting NUVESSA
Aqueous-based metronidazole gel formulations
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Aqueous-based metronidazole gel formulations
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF BACTERIAL VAGINOSIS
Compositions for increasing solubility of azole drug compounds that are poorly soluble in water
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF BACTERIAL VAGINOSIS WITH METRONIDAZOLE GEL
Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF BACTERIAL VAGINOSIS WITH METRONIDAZOLE GEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for NUVESSA
See the table below for patents covering NUVESSA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 103763925 | High dosage mucoadhesive metronidazole aqueous-based gel formulations their use to treat bacterial vaginosis | ⤷ Sign Up |
Japan | 6235087 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 2009097143 | ⤷ Sign Up | |
Brazil | 112013033759 | formulações de gel de base aquosa de metronidazol mucoadeseivo de alta dosagem e seu uso para tratar vaginose bacteriana | ⤷ Sign Up |
Mexico | 2014000066 | FORMULACIONES MUCOADHESIVAS EN GEL DE ALTA DOSIFICACIÓN DE METRONIDAZOL DE BASE ACUOSA Y SU USO PARA TRATAR LA VAGINOSIS BACTERIANA. (HIGH DOSAGE MUCOADHESIVE METRONIDAZOLE AQUEOUS-BASED GEL FORMULATIONS THEIR USE TO TREAT BACTERIAL VAGINOSIS.) | ⤷ Sign Up |
Australia | 2012275292 | High dosage mucoadhesive metronidazole aqueous-based gel formulations their use to treat bacterial vaginosis | ⤷ Sign Up |
European Patent Office | 2725904 | FORMULATIONS DE GEL À BASE DE MÉTRONIDAZOLE AQUEUX MUCOADHÉSIF À DOSAGE ÉLEVÉ ET LEUR UTILISATION POUR TRAITER UNE VAGINOSE BACTÉRIENNE (HIGH DOSAGE MUCOADHESIVE METRONIDAZOLE AQUEOUS-BASED GEL FORMULATIONS THEIR USE TO TREAT BACTERIAL VAGINOSIS) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for NUVESSA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0328535 | 96C0021 | Belgium | ⤷ Sign Up | PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |